Steven P. Treon, MD, MA, PhD
Dana-Farber Cancer Institute
4
4
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Thomas Witzig
Mayo Clinic
Shared therapeutic areas:
Ajay K. Gopal
Fred Hutch/University of Washington Cancer Consortium
Shared therapeutic areas:
Worked with same sponsors:
Adrian U Wiestner, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
M. Lia Palomba, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Jae Park, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
JS Kim, M.D, Ph.D
Severance Hospital, Yonsei University Health System
Shared therapeutic areas:
Ryotaro Nakamura
City of Hope Medical Center
Shared therapeutic areas:
Stanislaw R. Burzynski, MD, PhD
Burzynski Research Institute
Shared therapeutic areas:
Jennifer Johnson, MD, PhD
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Shared therapeutic areas:
Kenneth Meehan, MD
Dartmouth-Hitchcock Medical Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia
Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia
Sildenafil Citrate in Waldenstrom's Macroglobulinemia
Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia
All 4 trials loaded